219 related articles for article (PubMed ID: 12815042)
21. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.
Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P
J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428
[TBL] [Abstract][Full Text] [Related]
22. The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-beta repression of the sodium/iodide symporter gene.
Costamagna E; García B; Santisteban P
J Biol Chem; 2004 Jan; 279(5):3439-46. PubMed ID: 14623893
[TBL] [Abstract][Full Text] [Related]
23. Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway.
Furuhashi M; Yagi K; Yamamoto H; Furukawa Y; Shimada S; Nakamura Y; Kikuchi A; Miyazono K; Kato M
Mol Cell Biol; 2001 Aug; 21(15):5132-41. PubMed ID: 11438668
[TBL] [Abstract][Full Text] [Related]
24. CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation.
Xin H; Xu X; Li L; Ning H; Rong Y; Shang Y; Wang Y; Fu XY; Chang Z
J Biol Chem; 2005 May; 280(21):20842-50. PubMed ID: 15781469
[TBL] [Abstract][Full Text] [Related]
25. Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3.
Higashi K; Inagaki Y; Fujimori K; Nakao A; Kaneko H; Nakatsuka I
J Biol Chem; 2003 Oct; 278(44):43470-9. PubMed ID: 12917425
[TBL] [Abstract][Full Text] [Related]
26. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies.
Sachdev S; Bruhn L; Sieber H; Pichler A; Melchior F; Grosschedl R
Genes Dev; 2001 Dec; 15(23):3088-103. PubMed ID: 11731474
[TBL] [Abstract][Full Text] [Related]
27. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.
Felici A; Wurthner JU; Parks WT; Giam LR; Reiss M; Karpova TS; McNally JG; Roberts AB
EMBO J; 2003 Sep; 22(17):4465-77. PubMed ID: 12941698
[TBL] [Abstract][Full Text] [Related]
28. Evidence for a role of MSK1 in transforming growth factor-beta-mediated responses through p38alpha and Smad signaling pathways.
Abécassis L; Rogier E; Vazquez A; Atfi A; Bourgeade MF
J Biol Chem; 2004 Jul; 279(29):30474-9. PubMed ID: 15133024
[TBL] [Abstract][Full Text] [Related]
29. Interaction of Smad3 and SRF-associated complex mediates TGF-beta1 signals to regulate SM22 transcription during myofibroblast differentiation.
Qiu P; Feng XH; Li L
J Mol Cell Cardiol; 2003 Dec; 35(12):1407-20. PubMed ID: 14654367
[TBL] [Abstract][Full Text] [Related]
30. Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor beta 1-induced furin gene transactivation.
Blanchette F; Rivard N; Rudd P; Grondin F; Attisano L; Dubois CM
J Biol Chem; 2001 Sep; 276(36):33986-94. PubMed ID: 11448947
[TBL] [Abstract][Full Text] [Related]
31. Transactivation properties of c-Myb are critically dependent on two SUMO-1 acceptor sites that are conjugated in a PIASy enhanced manner.
Dahle Ø; Andersen TØ; Nordgård O; Matre V; Del Sal G; Gabrielsen OS
Eur J Biochem; 2003 Mar; 270(6):1338-48. PubMed ID: 12631292
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional activation of mouse mast cell Protease-7 by activin and transforming growth factor-beta is inhibited by microphthalmia-associated transcription factor.
Funaba M; Ikeda T; Murakami M; Ogawa K; Tsuchida K; Sugino H; Abe M
J Biol Chem; 2003 Dec; 278(52):52032-41. PubMed ID: 14527958
[TBL] [Abstract][Full Text] [Related]
33. Smad7 is a TGF-beta-inducible attenuator of Smad2/3-mediated inhibition of embryonic lung morphogenesis.
Zhao J; Crowe DL; Castillo C; Wuenschell C; Chai Y; Warburton D
Mech Dev; 2000 May; 93(1-2):71-81. PubMed ID: 10781941
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2.
Song K; Cornelius SC; Reiss M; Danielpour D
J Biol Chem; 2003 Oct; 278(40):38342-51. PubMed ID: 12876289
[TBL] [Abstract][Full Text] [Related]
35. A nuclear antagonistic mechanism of inhibitory Smads in transforming growth factor-beta signaling.
Bai S; Cao X
J Biol Chem; 2002 Feb; 277(6):4176-82. PubMed ID: 11711531
[TBL] [Abstract][Full Text] [Related]
36. Regulation of Smad7 promoter by direct association with Smad3 and Smad4.
Nagarajan RP; Zhang J; Li W; Chen Y
J Biol Chem; 1999 Nov; 274(47):33412-8. PubMed ID: 10559222
[TBL] [Abstract][Full Text] [Related]
37. Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation.
Ebisawa T; Fukuchi M; Murakami G; Chiba T; Tanaka K; Imamura T; Miyazono K
J Biol Chem; 2001 Apr; 276(16):12477-80. PubMed ID: 11278251
[TBL] [Abstract][Full Text] [Related]
38. PIASy-mediated repression of the androgen receptor is independent of sumoylation.
Gross M; Yang R; Top I; Gasper C; Shuai K
Oncogene; 2004 Apr; 23(17):3059-66. PubMed ID: 14981544
[TBL] [Abstract][Full Text] [Related]
39. Protein inhibitor of activated STAT, PIASy regulates α-smooth muscle actin expression by interacting with E12 in mesangial cells.
Torikoshi K; Abe H; Matsubara T; Hirano T; Ohshima T; Murakami T; Araki M; Mima A; Iehara N; Fukatsu A; Kita T; Arai H; Doi T
PLoS One; 2012; 7(7):e41186. PubMed ID: 22829926
[TBL] [Abstract][Full Text] [Related]
40. Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation.
Choy L; Skillington J; Derynck R
J Cell Biol; 2000 May; 149(3):667-82. PubMed ID: 10791980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
